AngioDynamics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- AngioDynamics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ANGO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001275187
Board of directors
-
Dennis S. Meteny · DirectorSince 2023
-
Eileen O'Shea Auen · DirectorSince 2023
-
Howard W. Donnelly · DirectorSince 2023
-
James C. Clemmer · Director · President and CEOSince 2023
-
Jan Stern Reed · DirectorSince 2023
-
Karen A. Licitra · DirectorSince 2023
-
Lorinda Burgess · DirectorSince 2023
-
Michael E. Tarnoff · DirectorSince 2023
-
Wesley Johnson · DirectorSince 2023
Chief executives
James C. Clemmer
· President and CEO
Dates unknown
Board connections
2 of this board's directors also sit on 2 other boards.
- via Jan Stern Reed and Lorinda Burgess
- via Jan Stern Reed
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 21, 2024 | Campbell Chad Thomas Officer (SVP/GM, Vascular Access) | Shares withheld for tax | −395 | $7.13 | $2,816 |
| Jul 21, 2024 | Piccinini Laura Officer (SVP International) | Shares withheld for tax | −413 | $7.13 | $2,945 |
| Jul 21, 2024 | James C. Clemmer Director, Officer (President and CEO) | Shares withheld for tax | −3,372 | $7.13 | $24,042 |
| Jul 21, 2024 | Nighan Warren JR Officer (SVP Quality and Regulatory) | Shares withheld for tax | −277 | $7.13 | $1,975 |
| Jul 21, 2024 | Trowbridge Stephen A Officer (EVP and CFO) | Shares withheld for tax | −667 | $7.13 | $4,756 |
| Jul 20, 2024 | Campbell Chad Thomas Officer (SVP/GM, Vascular Access) | Shares withheld for tax | −359 | $7.13 | $2,560 |
| Jul 20, 2024 | Piccinini Laura Officer (SVP International) | Shares withheld for tax | −616 | $7.13 | $4,392 |
| Jul 20, 2024 | James C. Clemmer Director, Officer (President and CEO) | Shares withheld for tax | −2,982 | $7.13 | $21,262 |
| Jul 20, 2024 | Nighan Warren JR Officer (SVP Quality and Regulatory) | Shares withheld for tax | −251 | $7.13 | $1,790 |
| Jul 20, 2024 | Trowbridge Stephen A Officer (EVP and CFO) | Shares withheld for tax | −717 | $7.13 | $5,112 |
| Jul 19, 2024 | James C. Clemmer Director, Officer (President and CEO) | Grant or award | +3,817 | — | — |
| Jul 19, 2024 | Piccinini Laura Officer (SVP International) | Shares withheld for tax | −1,983 | $7.18 | $14,238 |
| Jul 19, 2024 | Nighan Warren JR Officer (SVP Quality and Regulatory) | Shares withheld for tax | −735 | $7.18 | $5,277 |
| Jul 19, 2024 | James C. Clemmer Director, Officer (President and CEO) | Shares withheld for tax | −8,307 | $7.18 | $59,644 |
| Jul 19, 2024 | Campbell Chad Thomas Officer (SVP/GM, Vascular Access) | Shares withheld for tax | −1,025 | $7.18 | $7,360 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.